The Biologics and Biosimilars market has witnessed growth from USD XX million to USD XX million from 2017 to 2022. With the CAGR of X.X%, this market is estimated to reach USD XX million in 2029.
The report focuses on the Biologics and Biosimilars market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides detailed cost analysis, supply chain.
Technological innovation and advancement will further optimize the performance of the product, making it more widely used in downstream applications. Moreover, Consumer behavior analysis and market dynamics (drivers, restraints, opportunities) provides crucial information for knowing the Biologics and Biosimilars market.
Key players in the global Biologics and Biosimilars market covered in Chapter 2 and Chapter 6:
Novo Nordisk
Pfizer
Merck
Changchun High Tech
CP Guojian
3sbio
Dong Bao
Johnson & Johnson
AbbVie
Gelgen
Roche
Innovent
Ganlee
Amgen
Biotech
Sanofi-Aventis
Novartis
Eli Lilly
In Chapter 8 and Chapter 10.3, based on types, the Biologics and Biosimilars market from 2017 to 2029 is primarily split into:
Monoclonal Antibodies
Interferon
Erythropoietin
Insulin
Vaccines
Other
In Chapter 9 and Chapter 10.4, based on applications, the Biologics and Biosimilars market from 2017 to 2029 covers:
Tumor
Diabetes
Cardiovascular
Hemophilia
Other
Geographically, the report includes the research on production, consumption, revenue, market share and growth rate, and forecast (2017 -2029) of the following regions:
United States
Europe (Germany, UK, France, Italy, Spain, Russia, Poland)
China
Japan
India
Southeast Asia (Malaysia, Singapore, Philippines, Indonesia, Thailand, Vietnam)
Latin America (Brazil, Mexico, Colombia)
Middle East and Africa (Saudi Arabia, United Arab Emirates, Turkey, Egypt, South Africa, Nigeria)
Other Regions
Chapter 1 provides an overview of Biologics and Biosimilars market, containing global revenue and CAGR. The forecast and analysis of Biologics and Biosimilars market by type, application, and region are also presented in this chapter.
Chapter 2 is about the market landscape and major players. It provides competitive situation and market concentration status along with the basic information of these players.
Chapter 3 introduces the industrial chain of Biologics and Biosimilars. Industrial chain analysis, raw material (suppliers, price, supply and demand, market concentration rate) and downstream buyers are analyzed in this chapter.
Chapter 4 concentrates on manufacturing analysis, including cost structure analysis and process analysis, making up a comprehensive analysis of manufacturing cost.
Chapter 5 provides clear insights into market dynamics, the influence of COVID-19 in Biologics and Biosimilars industry, consumer behavior analysis.
Chapter 6 provides a full-scale analysis of major players in Biologics and Biosimilars industry. The basic information, as well as the profiles, applications and specifications of products market performance along with Business Overview are offered.
Chapter 7 pays attention to the sales, revenue, price and gross margin of Biologics and Biosimilars in markets of different regions. The analysis on sales, revenue, price and gross margin of the global market is covered in this part.
Chapter 8 gives a worldwide view of Biologics and Biosimilars market. It includes sales, revenue, price, market share and the growth rate by type.
Chapter 9 focuses on the application of Biologics and Biosimilars, by analyzing the consumption and its growth rate of each application.
Chapter 10 prospects the whole Biologics and Biosimilars market, including the global sales and revenue forecast, regional forecast. It also foresees the Biologics and Biosimilars market by type and application.
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2029
2022-2029 Global Biologics and Biosimilars Professional Market Research Report, Analysis from Perspective of Segmentation (Competitor Landscape, Type, Application, and Geography)
Table of Content
1 Biologics and Biosimilars Market Overview
1.1 Product Overview and Scope of Biologics and Biosimilars
1.2 Biologics and Biosimilars Segment by Type
1.2.1 Global Biologics and Biosimilars Sales and CAGR (%) Comparison by Type (2017-2029)
1.2.2 The Market Profile of Monoclonal Antibodies
1.2.3 The Market Profile of Interferon
1.2.4 The Market Profile of Erythropoietin
1.2.5 The Market Profile of Insulin
1.2.6 The Market Profile of Vaccines
1.2.7 The Market Profile of Other
1.3 Global Biologics and Biosimilars Segment by Application
1.3.1 Biologics and Biosimilars Consumption (Sales) Comparison by Application (2017-2029)
1.3.2 The Market Profile of Tumor
1.3.3 The Market Profile of Diabetes
1.3.4 The Market Profile of Cardiovascular
1.3.5 The Market Profile of Hemophilia
1.3.6 The Market Profile of Other
1.4 Global Biologics and Biosimilars Market, Region Wise (2017-2022)
1.4.1 Global Biologics and Biosimilars Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2022)
1.4.2 United States Biologics and Biosimilars Market Status and Prospect (2017-2022)
1.4.3 Europe Biologics and Biosimilars Market Status and Prospect (2017-2022)
1.4.3.1 Germany Biologics and Biosimilars Market Status and Prospect (2017-2022)
1.4.3.2 UK Biologics and Biosimilars Market Status and Prospect (2017-2022)
1.4.3.3 France Biologics and Biosimilars Market Status and Prospect (2017-2022)
1.4.3.4 Italy Biologics and Biosimilars Market Status and Prospect (2017-2022)
1.4.3.5 Spain Biologics and Biosimilars Market Status and Prospect (2017-2022)
1.4.3.6 Russia Biologics and Biosimilars Market Status and Prospect (2017-2022)
1.4.3.7 Poland Biologics and Biosimilars Market Status and Prospect (2017-2022)
1.4.4 China Biologics and Biosimilars Market Status and Prospect (2017-2022)
1.4.5 Japan Biologics and Biosimilars Market Status and Prospect (2017-2022)
1.4.6 India Biologics and Biosimilars Market Status and Prospect (2017-2022)
1.4.7 Southeast Asia Biologics and Biosimilars Market Status and Prospect (2017-2022)
1.4.7.1 Malaysia Biologics and Biosimilars Market Status and Prospect (2017-2022)
1.4.7.2 Singapore Biologics and Biosimilars Market Status and Prospect (2017-2022)
1.4.7.3 Philippines Biologics and Biosimilars Market Status and Prospect (2017-2022)
1.4.7.4 Indonesia Biologics and Biosimilars Market Status and Prospect (2017-2022)
1.4.7.5 Thailand Biologics and Biosimilars Market Status and Prospect (2017-2022)
1.4.7.6 Vietnam Biologics and Biosimilars Market Status and Prospect (2017-2022)
1.4.8 Latin America Biologics and Biosimilars Market Status and Prospect (2017-2022)
1.4.8.1 Brazil Biologics and Biosimilars Market Status and Prospect (2017-2022)
1.4.8.2 Mexico Biologics and Biosimilars Market Status and Prospect (2017-2022)
1.4.8.3 Colombia Biologics and Biosimilars Market Status and Prospect (2017-2022)
1.4.9 Middle East and Africa Biologics and Biosimilars Market Status and Prospect (2017-2022)
1.4.9.1 Saudi Arabia Biologics and Biosimilars Market Status and Prospect (2017-2022)
1.4.9.2 United Arab Emirates Biologics and Biosimilars Market Status and Prospect (2017-2022)
1.4.9.3 Turkey Biologics and Biosimilars Market Status and Prospect (2017-2022)
1.4.9.4 Egypt Biologics and Biosimilars Market Status and Prospect (2017-2022)
1.4.9.5 South Africa Biologics and Biosimilars Market Status and Prospect (2017-2022)
1.4.9.6 Nigeria Biologics and Biosimilars Market Status and Prospect (2017-2022)
1.5 Global Market Size of Biologics and Biosimilars (2017-2029)
1.5.1 Global Biologics and Biosimilars Revenue Status and Outlook (2017-2029)
1.5.2 Global Biologics and Biosimilars Sales Status and Outlook (2017-2029)
2 Global Biologics and Biosimilars Market Landscape by Player
2.1 Global Biologics and Biosimilars Sales and Share by Player (2017-2022)
2.2 Global Biologics and Biosimilars Revenue and Market Share by Player (2017-2022)
2.3 Global Biologics and Biosimilars Average Price by Player (2017-2022)
2.4 Global Biologics and Biosimilars Gross Margin by Player (2017-2022)
2.5 Biologics and Biosimilars Manufacturing Base Distribution, Sales Area and Product Type by Player
2.6 Biologics and Biosimilars Market Competitive Situation and Trends
2.6.1 Biologics and Biosimilars Market Concentration Rate
2.6.2 Biologics and Biosimilars Market Share of Top 3 and Top 6 Players
2.6.3 Mergers & Acquisitions, Expansion
3 Biologics and Biosimilars Upstream and Downstream Analysis
3.1 Biologics and Biosimilars Industrial Chain Analysis
3.2 Key Raw Materials Suppliers and Price Analysis
3.3 Key Raw Materials Supply and Demand Analysis
3.4 Manufacturing Process Analysis
3.5 Market Concentration Rate of Raw Materials
3.6 Downstream Buyers
3.7 Value Chain Status Under COVID-18
4 Biologics and Biosimilars Manufacturing Cost Analysis
4.1 Manufacturing Cost Structure Analysis
4.2 Biologics and Biosimilars Key Raw Materials Cost Analysis
4.2.1 Key Raw Materials Introduction
4.2.2 Price Trend of Key Raw Materials
4.3 Labor Cost Analysis
4.3.1 Labor Cost of Biologics and Biosimilars Under COVID-19
4.4 Energy Costs Analysis
4.5 R&D Costs Analysis
5 Market Dynamics
5.1 Drivers
5.2 Restraints and Challenges
5.3 Opportunities
5.3.1 Advances in Innovation and Technology for Biologics and Biosimilars
5.3.2 Increased Demand in Emerging Markets
5.4 Biologics and Biosimilars Industry Development Trends under COVID-19 Outbreak
5.4.1 Global COVID-19 Status Overview
5.4.2 Influence of COVID-19 Outbreak on Biologics and Biosimilars Industry Development
5.5 Consumer Behavior Analysis
6 Players Profiles
6.1 Novo Nordisk
6.1.1 Novo Nordisk Basic Information, Manufacturing Base, Sales Area and Competitors
6.1.2 Biologics and Biosimilars Product Profiles, Application and Specification
6.1.3 Novo Nordisk Biologics and Biosimilars Market Performance (2017-2022)
6.1.4 Novo Nordisk Business Overview
6.2 Pfizer
6.2.1 Pfizer Basic Information, Manufacturing Base, Sales Area and Competitors
6.2.2 Biologics and Biosimilars Product Profiles, Application and Specification
6.2.3 Pfizer Biologics and Biosimilars Market Performance (2017-2022)
6.2.4 Pfizer Business Overview
6.3 Merck
6.3.1 Merck Basic Information, Manufacturing Base, Sales Area and Competitors
6.3.2 Biologics and Biosimilars Product Profiles, Application and Specification
6.3.3 Merck Biologics and Biosimilars Market Performance (2017-2022)
6.3.4 Merck Business Overview
6.4 Changchun High Tech
6.4.1 Changchun High Tech Basic Information, Manufacturing Base, Sales Area and Competitors
6.4.2 Biologics and Biosimilars Product Profiles, Application and Specification
6.4.3 Changchun High Tech Biologics and Biosimilars Market Performance (2017-2022)
6.4.4 Changchun High Tech Business Overview
6.5 CP Guojian
6.5.1 CP Guojian Basic Information, Manufacturing Base, Sales Area and Competitors
6.5.2 Biologics and Biosimilars Product Profiles, Application and Specification
6.5.3 CP Guojian Biologics and Biosimilars Market Performance (2017-2022)
6.5.4 CP Guojian Business Overview
6.6 3sbio
6.6.1 3sbio Basic Information, Manufacturing Base, Sales Area and Competitors
6.6.2 Biologics and Biosimilars Product Profiles, Application and Specification
6.6.3 3sbio Biologics and Biosimilars Market Performance (2017-2022)
6.6.4 3sbio Business Overview
6.7 Dong Bao
6.7.1 Dong Bao Basic Information, Manufacturing Base, Sales Area and Competitors
6.7.2 Biologics and Biosimilars Product Profiles, Application and Specification
6.7.3 Dong Bao Biologics and Biosimilars Market Performance (2017-2022)
6.7.4 Dong Bao Business Overview
6.8 Johnson & Johnson
6.8.1 Johnson & Johnson Basic Information, Manufacturing Base, Sales Area and Competitors
6.8.2 Biologics and Biosimilars Product Profiles, Application and Specification
6.8.3 Johnson & Johnson Biologics and Biosimilars Market Performance (2017-2022)
6.8.4 Johnson & Johnson Business Overview
6.9 AbbVie
6.9.1 AbbVie Basic Information, Manufacturing Base, Sales Area and Competitors
6.9.2 Biologics and Biosimilars Product Profiles, Application and Specification
6.9.3 AbbVie Biologics and Biosimilars Market Performance (2017-2022)
6.9.4 AbbVie Business Overview
6.10 Gelgen
6.10.1 Gelgen Basic Information, Manufacturing Base, Sales Area and Competitors
6.10.2 Biologics and Biosimilars Product Profiles, Application and Specification
6.10.3 Gelgen Biologics and Biosimilars Market Performance (2017-2022)
6.10.4 Gelgen Business Overview
6.11 Roche
6.11.1 Roche Basic Information, Manufacturing Base, Sales Area and Competitors
6.11.2 Biologics and Biosimilars Product Profiles, Application and Specification
6.11.3 Roche Biologics and Biosimilars Market Performance (2017-2022)
6.11.4 Roche Business Overview
6.12 Innovent
6.12.1 Innovent Basic Information, Manufacturing Base, Sales Area and Competitors
6.12.2 Biologics and Biosimilars Product Profiles, Application and Specification
6.12.3 Innovent Biologics and Biosimilars Market Performance (2017-2022)
6.12.4 Innovent Business Overview
6.13 Ganlee
6.13.1 Ganlee Basic Information, Manufacturing Base, Sales Area and Competitors
6.13.2 Biologics and Biosimilars Product Profiles, Application and Specification
6.13.3 Ganlee Biologics and Biosimilars Market Performance (2017-2022)
6.13.4 Ganlee Business Overview
6.14 Amgen
6.14.1 Amgen Basic Information, Manufacturing Base, Sales Area and Competitors
6.14.2 Biologics and Biosimilars Product Profiles, Application and Specification
6.14.3 Amgen Biologics and Biosimilars Market Performance (2017-2022)
6.14.4 Amgen Business Overview
6.15 Biotech
6.15.1 Biotech Basic Information, Manufacturing Base, Sales Area and Competitors
6.15.2 Biologics and Biosimilars Product Profiles, Application and Specification
6.15.3 Biotech Biologics and Biosimilars Market Performance (2017-2022)
6.15.4 Biotech Business Overview
6.16 Sanofi-Aventis
6.16.1 Sanofi-Aventis Basic Information, Manufacturing Base, Sales Area and Competitors
6.16.2 Biologics and Biosimilars Product Profiles, Application and Specification
6.16.3 Sanofi-Aventis Biologics and Biosimilars Market Performance (2017-2022)
6.16.4 Sanofi-Aventis Business Overview
6.17 Novartis
6.17.1 Novartis Basic Information, Manufacturing Base, Sales Area and Competitors
6.17.2 Biologics and Biosimilars Product Profiles, Application and Specification
6.17.3 Novartis Biologics and Biosimilars Market Performance (2017-2022)
6.17.4 Novartis Business Overview
6.18 Eli Lilly
6.18.1 Eli Lilly Basic Information, Manufacturing Base, Sales Area and Competitors
6.18.2 Biologics and Biosimilars Product Profiles, Application and Specification
6.18.3 Eli Lilly Biologics and Biosimilars Market Performance (2017-2022)
6.18.4 Eli Lilly Business Overview
7 Global Biologics and Biosimilars Sales and Revenue Region Wise (2017-2022)
7.1 Global Biologics and Biosimilars Sales and Market Share, Region Wise (2017-2022)
7.2 Global Biologics and Biosimilars Revenue (Revenue) and Market Share, Region Wise (2017-2022)
7.3 Global Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2017-2022)
7.4 United States Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2017-2022)
7.4.1 United States Biologics and Biosimilars Market Under COVID-19
7.5 Europe Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2017-2022)
7.5.1 Europe Biologics and Biosimilars Market Under COVID-19
7.6 China Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2017-2022)
7.6.1 China Biologics and Biosimilars Market Under COVID-19
7.7 Japan Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2017-2022)
7.7.1 Japan Biologics and Biosimilars Market Under COVID-19
7.8 India Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2017-2022)
7.8.1 India Biologics and Biosimilars Market Under COVID-19
7.9 Southeast Asia Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2017-2022)
7.9.1 Southeast Asia Biologics and Biosimilars Market Under COVID-19
7.10 Latin America Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2017-2022)
7.10.1 Latin America Biologics and Biosimilars Market Under COVID-19
7.11 Middle East and Africa Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2017-2022)
7.11.1 Middle East and Africa Biologics and Biosimilars Market Under COVID-19
8 Global Biologics and Biosimilars Sales, Revenue (Revenue), Price Trend by Type
8.1 Global Biologics and Biosimilars Sales and Market Share by Type (2017-2022)
8.2 Global Biologics and Biosimilars Revenue and Market Share by Type (2017-2022)
8.3 Global Biologics and Biosimilars Price by Type (2017-2022)
8.4 Global Biologics and Biosimilars Sales Growth Rate by Type (2017-2022)
8.4.1 Global Biologics and Biosimilars Sales Growth Rate of Monoclonal Antibodies (2017-2022)
8.4.2 Global Biologics and Biosimilars Sales Growth Rate of Interferon (2017-2022)
8.4.3 Global Biologics and Biosimilars Sales Growth Rate of Erythropoietin (2017-2022)
8.4.4 Global Biologics and Biosimilars Sales Growth Rate of Insulin (2017-2022)
8.4.5 Global Biologics and Biosimilars Sales Growth Rate of Vaccines (2017-2022)
8.4.6 Global Biologics and Biosimilars Sales Growth Rate of Other (2017-2022)
9 Global Biologics and Biosimilars Market Analysis by Application
9.1 Global Biologics and Biosimilars Consumption and Market Share by Application (2017-2022)
9.2 Global Biologics and Biosimilars Consumption Growth Rate by Application (2017-2022)
9.2.1 Global Biologics and Biosimilars Consumption Growth Rate of Tumor (2017-2022)
9.2.2 Global Biologics and Biosimilars Consumption Growth Rate of Diabetes (2017-2022)
9.2.3 Global Biologics and Biosimilars Consumption Growth Rate of Cardiovascular (2017-2022)
9.2.4 Global Biologics and Biosimilars Consumption Growth Rate of Hemophilia (2017-2022)
9.2.5 Global Biologics and Biosimilars Consumption Growth Rate of Other (2017-2022)
10 Global Biologics and Biosimilars Market Forecast (2022-2029)
10.1 Global Biologics and Biosimilars Sales, Revenue Forecast (2022-2029)
10.1.1 Global Biologics and Biosimilars Sales and Growth Rate Forecast (2022-2029)
10.1.2 Global Biologics and Biosimilars Revenue and Growth Rate Forecast (2022-2029)
10.1.3 Global Biologics and Biosimilars Price and Trend Forecast (2022-2029)
10.2 Global Biologics and Biosimilars Sales and Revenue Forecast, Region Wise (2022-2029)
10.2.1 United States Biologics and Biosimilars Sales and Revenue Forecast (2022-2029)
10.2.2 Europe Biologics and Biosimilars Sales and Revenue Forecast (2022-2029)
10.2.3 China Biologics and Biosimilars Sales and Revenue Forecast (2022-2029)
10.2.4 Japan Biologics and Biosimilars Sales and Revenue Forecast (2022-2029)
10.2.5 India Biologics and Biosimilars Sales and Revenue Forecast (2022-2029)
10.2.6 Southeast Asia Biologics and Biosimilars Sales and Revenue Forecast (2022-2029)
10.2.7 Latin America Biologics and Biosimilars Sales and Revenue Forecast (2022-2029)
10.2.8 Middle East and Africa Biologics and Biosimilars Sales and Revenue Forecast (2022-2029)
10.3 Global Biologics and Biosimilars Sales, Revenue and Price Forecast by Type (2022-2029)
10.4 Global Biologics and Biosimilars Consumption Forecast by Application (2022-2029)
10.5 Biologics and Biosimilars Market Forecast Under COVID-19
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Data Source
List of Tables and Figures
Figure Biologics and Biosimilars Product Picture
Table Global Biologics and Biosimilars Sales and CAGR (%) Comparison by Type
Table Profile of Monoclonal Antibodies
Table Profile of Interferon
Table Profile of Erythropoietin
Table Profile of Insulin
Table Profile of Vaccines
Table Profile of Other
Table Biologics and Biosimilars Consumption (Sales) Comparison by Application (2017-2029)
Table Profile of Tumor
Table Profile of Diabetes
Table Profile of Cardiovascular
Table Profile of Hemophilia
Table Profile of Other
Figure Global Biologics and Biosimilars Market Size (Revenue) and CAGR (%) (2017-2022)
Figure United States Biologics and Biosimilars Revenue and Growth Rate (2017-2022)
Figure Europe Biologics and Biosimilars Revenue and Growth Rate (2017-2022)
Figure Germany Biologics and Biosimilars Revenue and Growth Rate (2017-2022)
Figure UK Biologics and Biosimilars Revenue and Growth Rate (2017-2022)
Figure France Biologics and Biosimilars Revenue and Growth Rate (2017-2022)
Figure Italy Biologics and Biosimilars Revenue and Growth Rate (2017-2022)
Figure Spain Biologics and Biosimilars Revenue and Growth Rate (2017-2022)
Figure Russia Biologics and Biosimilars Revenue and Growth Rate (2017-2022)
Figure Poland Biologics and Biosimilars Revenue and Growth Rate (2017-2022)
Figure China Biologics and Biosimilars Revenue and Growth Rate (2017-2022)
Figure Japan Biologics and Biosimilars Revenue and Growth Rate (2017-2022)
Figure India Biologics and Biosimilars Revenue and Growth Rate (2017-2022)
Figure Southeast Asia Biologics and Biosimilars Revenue and Growth Rate (2017-2022)
Figure Malaysia Biologics and Biosimilars Revenue and Growth Rate (2017-2022)
Figure Singapore Biologics and Biosimilars Revenue and Growth Rate (2017-2022)
Figure Philippines Biologics and Biosimilars Revenue and Growth Rate (2017-2022)
Figure Indonesia Biologics and Biosimilars Revenue and Growth Rate (2017-2022)
Figure Thailand Biologics and Biosimilars Revenue and Growth Rate (2017-2022)
Figure Vietnam Biologics and Biosimilars Revenue and Growth Rate (2017-2022)
Figure Latin America Biologics and Biosimilars Revenue and Growth Rate (2017-2022)
Figure Brazil Biologics and Biosimilars Revenue and Growth Rate (2017-2022)
Figure Mexico Biologics and Biosimilars Revenue and Growth Rate (2017-2022)
Figure Colombia Biologics and Biosimilars Revenue and Growth Rate (2017-2022)
Figure Middle East and Africa Biologics and Biosimilars Revenue and Growth Rate (2017-2022)
Figure Saudi Arabia Biologics and Biosimilars Revenue and Growth Rate (2017-2022)
Figure United Arab Emirates Biologics and Biosimilars Revenue and Growth Rate (2017-2022)
Figure Turkey Biologics and Biosimilars Revenue and Growth Rate (2017-2022)
Figure Egypt Biologics and Biosimilars Revenue and Growth Rate (2017-2022)
Figure South Africa Biologics and Biosimilars Revenue and Growth Rate (2017-2022)
Figure Nigeria Biologics and Biosimilars Revenue and Growth Rate (2017-2022)
Figure Global Biologics and Biosimilars Sales Status and Outlook (2017-2029)
Table Global Biologics and Biosimilars Sales by Player (2017-2022)
Table Global Biologics and Biosimilars Sales Share by Player (2017-2022)
Figure Global Biologics and Biosimilars Sales Share by Player in 2021
Table Biologics and Biosimilars Revenue by Player (2017-2022)
Table Biologics and Biosimilars Revenue Market Share by Player (2017-2022)
Table Biologics and Biosimilars Price by Player (2017-2022)
Table Biologics and Biosimilars Gross Margin by Player (2017-2022)
Table Biologics and Biosimilars Manufacturing Base Distribution and Sales Area by Player
Table Biologics and Biosimilars Product Type by Player
Table Mergers & Acquisitions, Expansion Plans
Figure Biologics and Biosimilars Industrial Chain Analysis
Table Key Raw Materials Suppliers and Price Analysis
Figure Market Concentration Rate of Raw Materials
Table Downstream Buyers
Figure Manufacturing Cost Structure Analysis
Table Key Raw Materials Introduction of Biologics and Biosimilars
Figure Price Trend of Key Raw Materials
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Biologics and Biosimilars Industry Development
Table Novo Nordisk Profile
Table Biologics and Biosimilars Product Profiles, Application and Specification
Table Novo Nordisk Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2017-2022)
Figure Novo Nordisk Revenue and Growth Rate
Figure Novo Nordisk Revenue Market Share 2017-2022
Table Pfizer Profile
Table Biologics and Biosimilars Product Profiles, Application and Specification
Table Pfizer Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2017-2022)
Figure Pfizer Revenue and Growth Rate
Figure Pfizer Revenue Market Share 2017-2022
Table Merck Profile
Table Biologics and Biosimilars Product Profiles, Application and Specification
Table Merck Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2017-2022)
Figure Merck Revenue and Growth Rate
Figure Merck Revenue Market Share 2017-2022
Table Changchun High Tech Profile
Table Biologics and Biosimilars Product Profiles, Application and Specification
Table Changchun High Tech Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2017-2022)
Figure Changchun High Tech Revenue and Growth Rate
Figure Changchun High Tech Revenue Market Share 2017-2022
Table CP Guojian Profile
Table Biologics and Biosimilars Product Profiles, Application and Specification
Table CP Guojian Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2017-2022)
Figure CP Guojian Revenue and Growth Rate
Figure CP Guojian Revenue Market Share 2017-2022
Table 3sbio Profile
Table Biologics and Biosimilars Product Profiles, Application and Specification
Table 3sbio Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2017-2022)
Figure 3sbio Revenue and Growth Rate
Figure 3sbio Revenue Market Share 2017-2022
Table Dong Bao Profile
Table Biologics and Biosimilars Product Profiles, Application and Specification
Table Dong Bao Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2017-2022)
Figure Dong Bao Revenue and Growth Rate
Figure Dong Bao Revenue Market Share 2017-2022
Table Johnson & Johnson Profile
Table Biologics and Biosimilars Product Profiles, Application and Specification
Table Johnson & Johnson Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2017-2022)
Figure Johnson & Johnson Revenue and Growth Rate
Figure Johnson & Johnson Revenue Market Share 2017-2022
Table AbbVie Profile
Table Biologics and Biosimilars Product Profiles, Application and Specification
Table AbbVie Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2017-2022)
Figure AbbVie Revenue and Growth Rate
Figure AbbVie Revenue Market Share 2017-2022
Table Gelgen Profile
Table Biologics and Biosimilars Product Profiles, Application and Specification
Table Gelgen Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2017-2022)
Figure Gelgen Revenue and Growth Rate
Figure Gelgen Revenue Market Share 2017-2022
Table Roche Profile
Table Biologics and Biosimilars Product Profiles, Application and Specification
Table Roche Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2017-2022)
Figure Roche Revenue and Growth Rate
Figure Roche Revenue Market Share 2017-2022
Table Innovent Profile
Table Biologics and Biosimilars Product Profiles, Application and Specification
Table Innovent Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2017-2022)
Figure Innovent Revenue and Growth Rate
Figure Innovent Revenue Market Share 2017-2022
Table Ganlee Profile
Table Biologics and Biosimilars Product Profiles, Application and Specification
Table Ganlee Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2017-2022)
Figure Ganlee Revenue and Growth Rate
Figure Ganlee Revenue Market Share 2017-2022
Table Amgen Profile
Table Biologics and Biosimilars Product Profiles, Application and Specification
Table Amgen Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2017-2022)
Figure Amgen Revenue and Growth Rate
Figure Amgen Revenue Market Share 2017-2022
Table Biotech Profile
Table Biologics and Biosimilars Product Profiles, Application and Specification
Table Biotech Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2017-2022)
Figure Biotech Revenue and Growth Rate
Figure Biotech Revenue Market Share 2017-2022
Table Sanofi-Aventis Profile
Table Biologics and Biosimilars Product Profiles, Application and Specification
Table Sanofi-Aventis Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2017-2022)
Figure Sanofi-Aventis Revenue and Growth Rate
Figure Sanofi-Aventis Revenue Market Share 2017-2022
Table Novartis Profile
Table Biologics and Biosimilars Product Profiles, Application and Specification
Table Novartis Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2017-2022)
Figure Novartis Revenue and Growth Rate
Figure Novartis Revenue Market Share 2017-2022
Table Eli Lilly Profile
Table Biologics and Biosimilars Product Profiles, Application and Specification
Table Eli Lilly Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2017-2022)
Figure Eli Lilly Revenue and Growth Rate
Figure Eli Lilly Revenue Market Share 2017-2022
Table Global Biologics and Biosimilars Sales, Region Wise (2017-2022)
Table Global Biologics and Biosimilars Sales Market Share, Region Wise (2017-2022)
Figure Global Biologics and Biosimilars Sales Market Share, Region Wise (2017-2022)
Figure Global Biologics and Biosimilars Sales Market Share, Region Wise in 2021
Table Global Biologics and Biosimilars Revenue, Region Wise (2017-2022)
Table Global Biologics and Biosimilars Revenue Market Share, Region Wise (2017-2022)
Figure Global Biologics and Biosimilars Revenue Market Share, Region Wise (2017-2022)
Figure Global Biologics and Biosimilars Revenue Market Share, Region Wise in 2021
Table Global Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2017-2022)
Table United States Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2017-2022)
Table Europe Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2017-2022)
Table China Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2017-2022)
Table Japan Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2017-2022)
Table India Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2017-2022)
Table Southeast Asia Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2017-2022)
Table Latin America Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2017-2022)
Table Middle East and Africa Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2017-2022)
Table Global Biologics and Biosimilars Sales by Type (2017-2022)
Table Global Biologics and Biosimilars Sales Market Share by Type (2017-2022)
Figure Global Biologics and Biosimilars Sales Market Share by Type in 2022
Table Global Biologics and Biosimilars Revenue by Type (2017-2022)
Table Global Biologics and Biosimilars Revenue Market Share by Type (2017-2022)
Figure Global Biologics and Biosimilars Revenue Market Share by Type in 2022
Table Biologics and Biosimilars Price by Type (2017-2022)
Figure Global Biologics and Biosimilars Sales Growth Rate of Monoclonal Antibodies (2017-2022)
Figure Global Biologics and Biosimilars Sales Growth Rate of Interferon (2017-2022)
Figure Global Biologics and Biosimilars Sales Growth Rate of Erythropoietin (2017-2022)
Figure Global Biologics and Biosimilars Sales Growth Rate of Insulin (2017-2022)
Figure Global Biologics and Biosimilars Sales Growth Rate of Vaccines (2017-2022)
Figure Global Biologics and Biosimilars Sales Growth Rate of Other (2017-2022)
Table Global Biologics and Biosimilars Consumption by Application (2017-2022)
Table Global Biologics and Biosimilars Consumption Market Share by Application (2017-2022)
Table Global Biologics and Biosimilars Consumption of Tumor (2017-2022)
Table Global Biologics and Biosimilars Consumption of Diabetes (2017-2022)
Table Global Biologics and Biosimilars Consumption of Cardiovascular (2017-2022)
Table Global Biologics and Biosimilars Consumption of Hemophilia (2017-2022)
Table Global Biologics and Biosimilars Consumption of Other (2017-2022)
Figure Global Biologics and Biosimilars Sales and Growth Rate Forecast (2022-2029)
Figure Global Biologics and Biosimilars Revenue and Growth Rate Forecast (2022-2029)
Figure Global Biologics and Biosimilars Price and Trend Forecast (2022-2029)
Figure USA Biologics and Biosimilars Market Sales and Growth Rate Forecast Analysis (2022-2029)
Figure USA Biologics and Biosimilars Market Revenue and Growth Rate Forecast Analysis (2022-2029)
Figure Europe Biologics and Biosimilars Market Sales and Growth Rate Forecast Analysis (2022-2029)
Figure Europe Biologics and Biosimilars Market Revenue and Growth Rate Forecast Analysis (2022-2029)
Figure China Biologics and Biosimilars Market Sales and Growth Rate Forecast Analysis (2022-2029)
Figure China Biologics and Biosimilars Market Revenue and Growth Rate Forecast Analysis (2022-2029)
Figure Japan Biologics and Biosimilars Market Sales and Growth Rate Forecast Analysis (2022-2029)
Figure Japan Biologics and Biosimilars Market Revenue and Growth Rate Forecast Analysis (2022-2029)
Figure India Biologics and Biosimilars Market Sales and Growth Rate Forecast Analysis (2022-2029)
Figure India Biologics and Biosimilars Market Revenue and Growth Rate Forecast Analysis (2022-2029)
Figure Southeast Asia Biologics and Biosimilars Market Sales and Growth Rate Forecast Analysis (2022-2029)
Figure Southeast Asia Biologics and Biosimilars Market Revenue and Growth Rate Forecast Analysis (2022-2029)
Figure Latin America Biologics and Biosimilars Market Sales and Growth Rate Forecast Analysis (2022-2029)
Figure Latin America Biologics and Biosimilars Market Revenue and Growth Rate Forecast Analysis (2022-2029)
Figure Middle East and Africa Biologics and Biosimilars Market Sales and Growth Rate Forecast Analysis (2022-2029)
Figure Middle East and Africa Biologics and Biosimilars Market Revenue and Growth Rate Forecast Analysis (2022-2029)
Table Global Biologics and Biosimilars Market Sales Forecast, by Type
Table Global Biologics and Biosimilars Sales Volume Market Share Forecast, by Type
Table Global Biologics and Biosimilars Market Revenue Forecast, by Type
Table Global Biologics and Biosimilars Revenue Market Share Forecast, by Type
Table Global Biologics and Biosimilars Price Forecast, by Type
Table Global Biologics and Biosimilars Market Consumption Forecast, by Application
Table Global Biologics and Biosimilars Consumption Volume Market Share Forecast, by Application
Table Global Biologics and Biosimilars Market Revenue Forecast, by Application
Table Global Biologics and Biosimilars Revenue Market Share Forecast, by Application
Table Global Biologics and Biosimilars Price Forecast, by Application
Global Biologics and Biosimilars Market Growth (Status and Outlook) 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 147
According to our LPI (LP Information) latest study, the global Biologics and Biosimilars market size was valued at US$ 458090 million in 2023. With growing demand in downstream market, the Biologics and Biosimilars is forecast to a readjusted size of US$ 837640 million by 2030 with a CAGR of 9.0% during review period.
The research report highlights the growth potential of the global Biologics and Biosimilars market. Biologics and Biosimilars are expected to show stable growth in the futu......
Global Biosimilar Drug Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 94
According to our LPI (LP Information) latest study, the global Biosimilar Drug market size was valued at US$ million in 2023. With growing demand in downstream market, the Biosimilar Drug is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Biosimilar Drug market. Biosimilar Drug are expected to show stable growth in the future market. However, product differentiation, reducing cost......
Global Biologics and Biosimilars Market 2024 by Company, Regions, Type and Application, Forecast to 2030
Published: 01-Jan-2024 Price: US 3480 Onwards Pages: 147
According to our (Global Info Research) latest study, the global Biologics and Biosimilars market size was valued at USD 481830 million in 2023 and is forecast to a readjusted size of USD 842330 million by 2030 with a CAGR of 8.3% during review period.
Biologics are very specific, highly effective medicines made in living cells, and historically this was often an animal. Biologics include hormones, cytokines, growth factors, vaccines, gene and cellular therapies, fusion proteins, insulin......
Global Biosimilars Market Research Report 2023, Forecast to 2028
Published: 27-Dec-2023 Price: US 2680 Onwards Pages: 167
A biosimilar is a biologic medical product (also known as biologic) highly similar to another already approved biological medicine (the 'reference medicine').
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technol......
Global Biosimilars Professional Survey Report 2023, Forecast to 2028
Published: 27-Dec-2023 Price: US 3280 Onwards Pages: 133
A biosimilar is a biologic medical product (also known as biologic) highly similar to another already approved biological medicine (the 'reference medicine').
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technol......
Global Biosimilars Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 07-Dec-2023 Price: US 3380 Onwards Pages: 106
Market Overview of Global Biosimilars market:
According to our latest research, the global Biosimilars market looks promising in the next 5 years. As of 2022, the global Biosimilars market was estimated at USD 8203.97 million, and it's anticipated to reach USD 40650.01 million in 2028, with a CAGR of 30.57% during the forecast years.
A biosimilar product is a biologic product that is approved based on demonstrating that it is highly similar to an FDA?approved biologic product......
Global Biologics and Biosimilars Professional Survey Report 2023, Forecast to 2028
Published: 24-Nov-2023 Price: US 3280 Onwards Pages: 134
Biologics include a wide variety of products such as gene and cell therapies, therapeutic proteins, monoclonal antibodies, and vaccines. Biosimilars are highly similar to the reference product in terms of safety, purity and potency, but may have minor differences in clinically inactive components.
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) da......
Global Biologics and Biosimilars Market Research Report 2023, Forecast to 2028
Published: 24-Nov-2023 Price: US 2680 Onwards Pages: 160
Biologics include a wide variety of products such as gene and cell therapies, therapeutic proteins, monoclonal antibodies, and vaccines. Biosimilars are highly similar to the reference product in terms of safety, purity and potency, but may have minor differences in clinically inactive components.
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) da......
Global Biosimilar Monoclonal Antibodies Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 16-Nov-2023 Price: US 3380 Onwards Pages: 103
Market Overview of Global Biosimilar Monoclonal Antibodies market:
According to our latest research, the global Biosimilar Monoclonal Antibodies market looks promising in the next 5 years. As of 2022, the global Biosimilar Monoclonal Antibodies market was estimated at USD 5156.19 million, and it's anticipated to reach USD 14274.14 million in 2028, with a CAGR of 18.5% during the forecast years.
This report covers a research time span from 2018 to 2028, and presents a deep and......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
